DavidsonX: Measuring Pharmacodynamics: From Ligand Binding to Clinical Outcomes
- Certification
- Certificate of completion
- Duration
- 3 weeks
- Price Value
- $ 199
- Difficulty Level
- Intermediate
"Measuring Biological Activity: From Molecules to Clinical Trials" is an engaging and comprehensive three-week course offered by DavidsonX that delves into the fascinating world of drug discovery and development. This intermediate-level course takes students on a journey through the various stages of measuring biological activity, from understanding drug targets at the molecular level to interpreting clinical trial results.
This course offers a flexible learning approach, allowing students to complete it in approximately three weeks at a pace of one hour per day, or in a more intensive format over a single week or extended weekend. With 15 modules, each consisting of instructional videos, readings, exercises, and assessments, students will gain a comprehensive understanding of measuring biological activity in drug discovery and development.
Explore more courses to enhance your cloud computing and Kubernetes skills.
Drugs are biologically active compounds. Drug discovery and drug development rely on methods for measuring biological activity. The term “activity” is quite general. In practice, a substance’s biological activity can refer to how a substance affects a biological pathway, cell-level responses, safety risks, how long a substance resides within in a system, as well as a substance’s effects in an organism (called pharmacodynamics). The design of methods for measuring activity is a critical aspect of drug discovery. The design of robust and informative methods can accelerate the drug discovery and development process.
Developed by leading researchers and clinicians from across Canada, this course will enhance knowledge and skills for clinicians who are using or beginning to use a biosimilar or biologic medicine in their professional practice setting.
Developed by leading researchers and clinicians from across Canada, this course will enhance knowledge and skills for patients who are using, or beginning to use, an originator or biosimilar biologic medicine.